Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.
about
Therapeutic targeting of the MYC signal by inhibition of histone chaperone FACT in neuroblastoma.Focal DNA copy number changes in neuroblastoma target MYCN regulated genesMYCN amplification predicts poor outcome for patients with supratentorial primitive neuroectodermal tumors of the central nervous systemTumor development, growth characteristics and spectrum of genetic aberrations in the TH-MYCN mouse model of neuroblastoma.Evaluation of clinically translatable MR imaging biomarkers of therapeutic response in the TH-MYCN transgenic mouse model of neuroblastomaIntrinsic susceptibility MRI identifies tumors with ALKF1174L mutation in genetically-engineered murine models of high-risk neuroblastomaNeuroblastoma: developmental biology, cancer genomics and immunotherapy.Activated ALK collaborates with MYCN in neuroblastoma pathogenesis.Targeting ALK in neuroblastoma--preclinical and clinical advancements.Investigating the Vascular Phenotype of Subcutaneously and Orthotopically Propagated PC3 Prostate Cancer Xenografts Using Combined Carbogen Ultrasmall Superparamagnetic Iron Oxide MRI.USP7 inhibitor P22077 inhibits neuroblastoma growth via inducing p53-mediated apoptosis.Pre-clinical imaging of transgenic mouse models of neuroblastoma using a dedicated 3-element solenoid coil on a clinical 3T platform.The MYCN Protein in Health and Disease.Short overview on metabolomics approach to study pathophysiology of oxidative stress in cancer.Glutathione biosynthesis is upregulated at the initiation of MYCN-driven neuroblastoma tumorigenesis.Prox1 identifies proliferating neuroblasts and nascent neurons during neurogenesis in sympathetic ganglia.The mutational landscape of MYCN, Lin28b and ALKF1174L driven murine neuroblastoma mimics human disease.ALK and GSK3: Shared Features of Neuroblastoma and Neural Crest Cells
P2860
Q27853237-631081B8-87EA-4B66-BF64-B3AD72535FCEQ28115604-589DFD60-7303-4327-A9C3-CF09B0EB37C3Q33753435-EE8E282F-B53C-4A30-BB32-869F51435515Q34531771-C843AAA7-4672-40B9-B46C-2EE0C54A96F0Q34983575-35B5B931-137B-4ED3-B203-35AEEE898390Q35131527-4E022D47-464A-4325-817E-BB43AA76DB00Q35283020-B5D05F19-C790-4C16-91C9-D1E9888244ADQ35861559-A5EFD851-4D19-4B15-8526-89B65310F5A0Q36933081-45E8941A-6A89-4F32-A5D5-1ABB77860E9DQ37347403-BC8B56B3-0116-44C3-B682-D362A15DC3DAQ37577477-3F361229-232D-4B15-90B5-0E7F338BCAEBQ38634667-71346A4C-B120-4746-8378-73710C1205AEQ39208675-FA623E7A-FF78-4BA2-9CB5-38D16C17FCB0Q41607194-B353342F-3BC0-4679-A6E8-8B220640C34DQ42282862-E5D14414-5A44-432B-8763-059AB7445067Q48273480-3BFDAF1E-7A93-44BA-BBA2-0AB5891A47CAQ50349505-6C2BC678-2892-446B-9FAB-F39196CAA9BCQ58786649-D858D66A-D480-4B51-A8C8-1C3762294E7C
P2860
Genetically engineered murine models--contribution to our understanding of the genetics, molecular pathology and therapeutic targeting of neuroblastoma.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Genetically engineered murine ...... ic targeting of neuroblastoma.
@en
Genetically engineered murine ...... ic targeting of neuroblastoma.
@nl
type
label
Genetically engineered murine ...... ic targeting of neuroblastoma.
@en
Genetically engineered murine ...... ic targeting of neuroblastoma.
@nl
prefLabel
Genetically engineered murine ...... ic targeting of neuroblastoma.
@en
Genetically engineered murine ...... ic targeting of neuroblastoma.
@nl
P2860
P1476
Genetically engineered murine ...... ic targeting of neuroblastoma.
@en
P2860
P304
P356
10.1016/J.SEMCANCER.2011.09.011
P577
2011-09-21T00:00:00Z